Isatuximab in Combination with Lenalidomide and Dexamethasone in Patients with High-Risk Smoldering Multiple Myeloma: Updated Safety Run-in Results from the Randomized Phase 3 Ithaca Study

María‐Victoria Mateos, Paula Rodríguez‐Otero, Youngil Koh, Joaquín Martínez‐López, Gurdeep Parmar, H. Miles Prince, Hang Quach, Paz Ribas, Emil Hermansen, Vânia Hungria, Sevgi Kalayoğlu Beşışık, Jin Seok Kim, Xavier Leleu, Valdas Pečeliūnas, Fredrik Schjesvold, Ömür Gökmen Sevindik, Т Е Лаврова, Franck Dubin, Christine Devisme, Lucie Lepine, Sandrine Macé, Mony Morisse, Irene M. Ghobrial